Pharma packaging to be $62B market by 2015; Batavia, Xendo ink manufacturing, marketing deal;

> The pharmaceuticals packaging market is expected to hit $62 billion by 2015, according to a new study from Freedonia Group, with 70% of demand coming from U.S., Japan and Western Europe, but China, India and Brazil will grow quickly as well. Report

> Batavia Bioservices has inked a deal to take over Xendo's bioprocess manufacturing, and the two companies will team up on marketing efforts. Story

> EMD Millipore, a division of Merck KGaA, has agreed to buy Amnis, which makes high-speed cell imaging instrumentation for flow cytometry uses. News

> Vivalis increased first-half sales by 165% and cut its net loss after landing two new licensing agreements for its EB66 technology used in vaccine production. Story

> France's Roquette wrapped up a capital-investment plan at its Lestrem facility, which makes injectable carbohydrates for use in parenteral drug manufacturing. Piece

> Contract manufacturing in Brazil is set to grow quickly, especially the manufacturing of APIs, market research firm RNCOS says in a new report. Report

> The Consumer Healthcare Products Association lodged some criticisms of the FDA's draft guidance on nanotechnology, including the agency's definition of the term. Article

Suggested Articles

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.

A warning letter says Chinese API maker Yibin Lihao Bio-technical was found lying to the FDA about manufacturing unapproved heparin.

It took four tries over four years, but Perrigo has finally gotten FDA approval of its generic of Teva’s tricky-to-make ProAir HFA asthma inhaler.